Skip to content

PrisMax System Version 2

by Baxter Healthcare Corp

510(k) K190910

PrisMax System Version 2 is a medical device (FDA Class II; FDA product code KDI, Dialyzer, High Permeability With Or Without Sealed Dialysate System) made by Baxter Healthcare Corp, cleared under FDA 510(k) K190910 on 25 Jul 2019, active as of 22 Oct 2026. 5 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK190910 Date25 Jul 2019ClearedStatusActive

Official records

Recalls

5 recalls · 3 ongoing · FDA

    • Ongoing Z-2437-2025 FDA Class II initiated 28 Jul 2025

    Low deaeration chamber level at post priming tests may lead to PrisMax System alarm T2309: Air Detected in Prime resulting in multiple additional priming cycles

    • Ongoing Z-2439-2025 FDA Class II initiated 28 Jul 2025

    Thermax System may be unable to detect the presence of a bag on the Thermax Blood Warmer Unit leading to difficulty setting up therapy, or PrisMax System alarm T2284: Thermax Disposable Not Inserted

    • Ongoing Z-0215-2022 FDA Class II initiated 29 Sep 2021

    If the operator initiates therapy with a saved prescription profile and makes a change to the prescription after a disposable filter change using the Same Patient button, the system may suggest values from the original prescription profile, rather than the current prescription.

    • Terminated Z-1151-2021 FDA Class II initiated 7 Jan 2021

    Variability in the performance of the tubing in the ARPS (Automatic Repositioning System) Pump Assembly which may lead to alarm situations during system self-test and therapy. This tubing is normally replaced during annual preventative maintenance. Alarm Situations: During System Self-Test: Alarm code B1215 (ARPS Self-Test failure); During Therapy: B1273 (ARPS Leak), B1215 (ARPS Pressure self-test), B1116 (Return Pressure self-test Failure), B1539 (Access Pod Reposition Failure), B1541 (Effluent Pod Reposition Failure), B1540 (Effluent Filter Pod Reposition Failure). If an alarm occurs, it may lead to delay or interruption of therapy. In the event that therapy is terminated without returning blood to the patient, blood loss may occur.

    • Terminated Z-0247-2020 FDA Class II initiated 19 Sep 2019

    TherMax Blood Warmers may not be in compliance with an electrical safety standard, which requires a protective earth connection that can sustain a current of 25 amps for 10 seconds.

Timeline

6 dated events

  1. Cleared FDA 510(k) K190910
  2. Recall initiated FDA recalls Z-0247-2020
  3. Recall initiated FDA recalls Z-1151-2021
  4. Recall initiated FDA recalls Z-0215-2022
  5. Recall initiated FDA recalls Z-2437-2025
  6. Recall initiated FDA recalls Z-2439-2025

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KDI
Device class
Class II
Regulation
21 CFR Part 876.5860
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KDI (Dialyzer, High Permeability With Or Without Sealed Dialysate System).

Other devices from Baxter Healthcare Corp

See all devices from Baxter Healthcare Corp →